Position in ALKS
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,157,297
+$69,603 QoQ
Shares Held
32,729
-15.8% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ProShare Advisors LLC holds $26,613,103 across 27 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
99,300 | $11,738,253 | |
| 2 | VTRS |
Viatris Inc
|
229,555 | $3,101,288 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
3,687 | $2,186,317 | |
| 4 | ALKS |
Alkermes plc.
This page
|
32,729 | $1,157,297 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
8,514 | $1,121,634 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
12,135 | $920,439 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
38,617 | $801,688 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
24,509 | $747,034 |
All Filings in ALKS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,157,297 | 32,729 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,087,694 | 38,874 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,094,910 | 36,497 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,213,693 | 42,422 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,495,343 | 45,286 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,616,628 | 56,211 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,229,796 | 43,937 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $868,829 | 36,051 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,222,806 | 45,172 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,160,142 | 41,822 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $908,812 | 32,446 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,011,897 | 32,329 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $862,275 | 30,588 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $968,482 | 37,064 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $768,330 | 34,408 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,004,637 | 33,724 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,329,681 | 50,539 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,439,235 | 61,876 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,814,625 | 58,840 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,869,576 | 76,247 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $467,504 | 25,027 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $547,029 | 27,420 | Shares | Sole | 2021-02-09 | |
| 2020-06-30 | $542,082 | 27,928 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $354,256 | 24,567 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||